1. Home
  2. APLS vs WRBY Comparison

APLS vs WRBY Comparison

Compare APLS & WRBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apellis Pharmaceuticals Inc.

APLS

Apellis Pharmaceuticals Inc.

N/A

Current Price

$17.28

Market Cap

2.7B

Sector

Health Care

ML Signal

N/A

Logo Warby Parker Inc.

WRBY

Warby Parker Inc.

N/A

Current Price

$23.08

Market Cap

2.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
APLS
WRBY
Founded
2009
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Ophthalmic Goods
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.9B
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
APLS
WRBY
Price
$17.28
$23.08
Analyst Decision
Buy
Buy
Analyst Count
21
13
Target Price
$31.65
$26.67
AVG Volume (30 Days)
1.9M
3.2M
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
112.50
105.88
EPS
0.20
0.01
Revenue
$1,003,782,000.00
$871,905,000.00
Revenue This Year
N/A
$14.63
Revenue Next Year
$18.21
$16.46
P/E Ratio
$86.38
$2,260.00
Revenue Growth
28.46
13.04
52 Week Low
$16.10
$13.63
52 Week High
$30.48
$31.00

Technical Indicators

Market Signals
Indicator
APLS
WRBY
Relative Strength Index (RSI) 27.60 45.96
Support Level $17.16 $21.47
Resistance Level $20.42 $28.86
Average True Range (ATR) 0.71 1.51
MACD -0.15 -0.14
Stochastic Oscillator 12.23 18.10

Price Performance

Historical Comparison
APLS
WRBY

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

About WRBY Warby Parker Inc.

Warby Parker Inc is a mission-driven, lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. The Company provides holistic vision care by offering eyewear, contacts, and eye care directly to consumers through its integrated, omnichannel platform. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.

Share on Social Networks: